Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 376

1.

Magnetic resonance imaging as a biomarker in renal cell carcinoma.

Pedrosa I, Alsop DC, Rofsky NM.

Cancer. 2009 May 15;115(10 Suppl):2334-45. doi: 10.1002/cncr.24237. Review.

2.

Arterial spin labeling blood flow magnetic resonance imaging for the characterization of metastatic renal cell carcinoma(1).

De Bazelaire C, Rofsky NM, Duhamel G, Michaelson MD, George D, Alsop DC.

Acad Radiol. 2005 Mar;12(3):347-57.

PMID:
15766695
3.

Magnetic resonance imaging-measured blood flow change after antiangiogenic therapy with PTK787/ZK 222584 correlates with clinical outcome in metastatic renal cell carcinoma.

de Bazelaire C, Alsop DC, George D, Pedrosa I, Wang Y, Michaelson MD, Rofsky NM.

Clin Cancer Res. 2008 Sep 1;14(17):5548-54. doi: 10.1158/1078-0432.CCR-08-0417.

5.

[MR imaging features of different renal cell carcinoma subtypes].

Wu B, Peng WJ, Gu YJ, Yang TX, Jiang ZX, Zhang HL, Dai B, Ye DW, Kong YY, Du X.

Zhonghua Zhong Liu Za Zhi. 2008 Nov;30(11):825-30. Chinese.

PMID:
19173827
6.

Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings.

Sun MR, Ngo L, Genega EM, Atkins MB, Finn ME, Rofsky NM, Pedrosa I.

Radiology. 2009 Mar;250(3):793-802. doi: 10.1148/radiol.2503080995.

PMID:
19244046
7.

Measuring perfusion and permeability in renal cell carcinoma with dynamic contrast-enhanced MRI: a pilot study.

Notohamiprodjo M, Sourbron S, Staehler M, Michaely HJ, Attenberger UI, Schmidt GP, Boehm H, Horng A, Glaser C, Stief C, Reiser MF, Herrmann KA.

J Magn Reson Imaging. 2010 Feb;31(2):490-501. doi: 10.1002/jmri.22028.

PMID:
20099364
8.

MR imaging of renal cell carcinoma: its role in determining cell type.

Yoshimitsu K, Irie H, Tajima T, Nishie A, Asayama Y, Hirakawa M, Nakayama T, Kakihara D, Honda H.

Radiat Med. 2004 Nov-Dec;22(6):371-6. Review.

PMID:
15648450
9.

Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia.

Tickoo SK, dePeralta-Venturina MN, Harik LR, Worcester HD, Salama ME, Young AN, Moch H, Amin MB.

Am J Surg Pathol. 2006 Feb;30(2):141-53.

PMID:
16434887
10.

Small renal cell carcinoma: MRI with pathologic correlation.

Shinmoto H, Yuasa Y, Tanimoto A, Narimatsu Y, Jinzaki M, Hiramatsu K, Mukai M.

J Magn Reson Imaging. 1998 May-Jun;8(3):690-4.

PMID:
9626888
11.

MR Imaging of papillary renal neoplasms: potential application for characterization of small renal masses.

Roy C, Sauer B, Lindner V, Lang H, Saussine C, Jacqmin D.

Eur Radiol. 2007 Jan;17(1):193-200. Epub 2006 Jun 7.

PMID:
16758161
12.

Renal cell carcinoma: t1 and t2 signal intensity characteristics of papillary and clear cell types correlated with pathology.

Oliva MR, Glickman JN, Zou KH, Teo SY, Mortelé KJ, Rocha MS, Silverman SG.

AJR Am J Roentgenol. 2009 Jun;192(6):1524-30. doi: 10.2214/AJR.08.1727.

PMID:
19457814
13.

Subtype differentiation of renal cell carcinoma using diffusion-weighted and blood oxygenation level-dependent MRI.

Choi YA, Kim CK, Park SY, Cho SW, Park BK.

AJR Am J Roentgenol. 2014 Jul;203(1):W78-84. doi: 10.2214/AJR.13.11551.

PMID:
24951231
14.

Diffusion-weighted intravoxel incoherent motion imaging of renal tumors with histopathologic correlation.

Chandarana H, Kang SK, Wong S, Rusinek H, Zhang JL, Arizono S, Huang WC, Melamed J, Babb JS, Suan EF, Lee VS, Sigmund EE.

Invest Radiol. 2012 Dec;47(12):688-96. doi: 10.1097/RLI.0b013e31826a0a49.

PMID:
22996315
15.

Combined diffusion-weighted, blood oxygen level-dependent, and dynamic contrast-enhanced MRI for characterization and differentiation of renal cell carcinoma.

Notohamiprodjo M, Staehler M, Steiner N, Schwab F, Sourbron SP, Michaely HJ, Helck AD, Reiser MF, Nikolaou K.

Acad Radiol. 2013 Jun;20(6):685-93. doi: 10.1016/j.acra.2013.01.015.

PMID:
23664397
16.

Comparing genomic and histologic correlations to radiographic changes in tumors: a murine SCC VII model study.

Yang YS, Guccione S, Bednarski MD.

Acad Radiol. 2003 Oct;10(10):1165-75.

PMID:
14587635
17.

Tumor Vascularity in Renal Masses: Correlation of Arterial Spin-Labeled and Dynamic Contrast-Enhanced Magnetic Resonance Imaging Assessments.

Zhang Y, Kapur P, Yuan Q, Xi Y, Carvo I, Signoretti S, Dimitrov I, Cadeddu JA, Margulis V, Muradyan N, Brugarolas J, Madhuranthakam AJ, Pedrosa I.

Clin Genitourin Cancer. 2016 Feb;14(1):e25-36. doi: 10.1016/j.clgc.2015.08.007. Epub 2015 Aug 29.

18.

Fat in liver metastasis from renal cell carcinoma detected by chemical shift MR imaging.

Nakayama T, Yoshimitsu K, Irie H, Aibe H, Tajima T, Shinozaki K, Nishie A, Kakihara D, Honda H.

Abdom Imaging. 2003 Sep-Oct;28(5):657-9.

PMID:
14628870
19.

Utility of MRI features in differentiation of central renal cell carcinoma and renal pelvic urothelial carcinoma.

Wehrli NE, Kim MJ, Matza BW, Melamed J, Taneja SS, Rosenkrantz AB.

AJR Am J Roentgenol. 2013 Dec;201(6):1260-7. doi: 10.2214/AJR.13.10673.

PMID:
24261365
20.

[Magnetic resonance imaging of angiogenesis in tumors].

Huwart L, Michoux N, Van Beers B.

J Radiol. 2007 Mar;88(3 Pt 1):331-8. Review. French.

Supplemental Content

Support Center